Ship Healthcare (3360) Q1 2026 earnings summary

Executive summary

• Net sales rose 5.2% year-over-year to ¥163,310 million for the quarter ended June 30, 2025, with performance in line with internal plans despite a back-loaded project schedule.

• Operating profit declined 15.8% year-over-year to ¥2,953 million due to project timing, but progress toward the full-year plan remains steady.

• Profit attributable to owners of parent dropped 34.1% year-over-year to ¥2,030 million, mainly due to project delivery timing in the Total Pack Produce segment.

• Group-wide integration and reorganization efforts continued, reducing the number of group companies and improving operational efficiency.

• The first year of the medium-term management plan “SHIP VISION 2030” commenced, focusing on new business creation, reorganization, and growth field expansion.

Financial highlights

• Gross profit increased slightly by 0.3% year-over-year to ¥13,733 million, with a gross margin of 8.4%.

• Operating profit margin decreased to 1.8% from 2.3% year-over-year.

• Ordinary profit dropped 31.0% year-over-year to ¥3,099 million, mainly due to a decrease in equity gains from affiliates.

• EPS for the quarter was ¥21.54, down from ¥32.66 in the prior year.

• Comprehensive income fell 30.0% year-over-year to ¥2,367 million.

Outlook and guidance

• Full-year net sales are projected at ¥700,000 million, with operating profit targeted at ¥26,000 million and ordinary profit at ¥26,500 million.

• Full-year forecast remains unchanged: net sales of ¥700,000 million (+3.2% YoY), operating profit of ¥26,000 million (+4.9% YoY), and profit attributable to owners of parent of ¥15,500 million (+2.5% YoY).

• Project deliveries are expected to be more heavily weighted toward the second half of the fiscal year.

• Interim dividend forecast is ¥0.00, with a year-end dividend of ¥60.00 per share.